Surgical Delays Due to COVID-19 are Associated with Shorter Survival Times in Patients with...
Surgical delays due to SARS-CoV-2 (COVID-19) are linked with shorter survival times in colorectal cancer, according to a new study published in the Journal...
Intraperitoneal Paclitaxel Addition May Be Beneficial for Patients with Pancreatic Cancer and Peritoneal Metastasis
A phase I/II study examined treatment strategies for patients with pancreatic cancer and peritoneal metastasis. After assessing a combination of intravenous gemcitabine, intravenous nab‐paclitaxel,...
Interview: Defactinib Plus Pembrolizumab and Gemcitabine Effective in Pancreatic Cancer Patients
A study presented as part of the American Association for Cancer Research virtual meeting found promising results for defactinib combined with pembrolizumab and gemcitabine...
Could A Blood Test Help Detect Pancreatic Cancer?
Blood-based biomarkers may help scientists identify pancreatic cancer at an early stage, a new study found—a significant finding that could help patients receive treatment...
Lynparza Approved for Advanced Pancreatic Cancer
The Food and Drug Administration granted approval for AstraZeneca and Merck’s Lynparza (olaparib) as a first-line maintenance therapy in adult patients with germline BRCA-mutated...
Pancreatic Cancer Treatment and Tumor Biology Differences by Race
A new study explored outcomes in pancreatic ductal adenocarcinoma by race, questioning whether treatment inequity, tumor biology, or both contribute to poorer outcomes among...
Classifying Pancreatic Cancer Tumors May Improve Treatment Options
The findings of a new study may help predict resistance to treatments for pancreatic cancer. The study was published in the journal Clinical Cancer...
